5-BROMOPYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID, 95.0%, 250mg

5-Bromoisoquinoline>96.0%(GC)(T)5g

(S)-1-(4,4-Dimethylcyclohexyl)ethanamine hydrochloride, 5g

Tetrafluorophthalic acid, 97.0%, 25g

5-tert-Butyl-1,3,4-oxadiazol-2-amine, 97.0%, 250mg

(4-Propoxyphenyl)methanol, 97.0%, 25g

5-Bromo-3-methoxypicolinaldehyde, 95.0%, 500mg

[1-(2,2,2-trifluoroethyl)azetidin-3-yl]methanol, 95.0%, 250mg

GC capillary column ROTI®Cap-1701, 25 m, 0.25 mm, 0.25 µm, 1 Piece(s)

9-(4-Bromobutyl)-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide, 95%, 250mg

1H-Indole-5-carboxamide, 97.0%, 250mg

Difenoconazole>95.0%(HPLC)(T)5g

1-(3-methylpiperazin-1-yl)-2-phenylethan-1-one, 95.0%, 5g